
Taiwo Oladapo
Examiner (ID: 13527, Phone: (571)270-3723 , Office: P/1771 )
| Most Active Art Unit | 1771 |
| Art Unit(s) | 1797, 1771 |
| Total Applications | 1276 |
| Issued Applications | 617 |
| Pending Applications | 137 |
| Abandoned Applications | 548 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5465001
[patent_doc_number] => 20090325201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Biomarkers for Detection and Diagnosis of Head and Neck Squamous Cell Carcinoma'
[patent_app_type] => utility
[patent_app_number] => 12/300523
[patent_app_country] => US
[patent_app_date] => 2007-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12177
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325201.pdf
[firstpage_image] =>[orig_patent_app_number] => 12300523
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/300523 | Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma | May 13, 2007 | Issued |
Array
(
[id] => 5230769
[patent_doc_number] => 20070292876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'METHODS FOR IDENTIFICATION OF COMPOUNDS THAT MIMIC THE SENESCENCE-INDUCING ACTIVITY OF RETINOIC ACID RECEPTOR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 11/743304
[patent_app_country] => US
[patent_app_date] => 2007-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4754
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20070292876.pdf
[firstpage_image] =>[orig_patent_app_number] => 11743304
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/743304 | METHODS FOR IDENTIFICATION OF COMPOUNDS THAT MIMIC THE SENESCENCE-INDUCING ACTIVITY OF RETINOIC ACID RECEPTOR LIGANDS | May 1, 2007 | Abandoned |
Array
(
[id] => 5210416
[patent_doc_number] => 20070249000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'METHOD FOR DIAGNOSING A PERSON HAVING B-CELL PATHOLOGIES'
[patent_app_type] => utility
[patent_app_number] => 11/740272
[patent_app_country] => US
[patent_app_date] => 2007-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5873
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20070249000.pdf
[firstpage_image] =>[orig_patent_app_number] => 11740272
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/740272 | METHOD FOR DIAGNOSING A PERSON HAVING B-CELL PATHOLOGIES | Apr 24, 2007 | Abandoned |
Array
(
[id] => 5490849
[patent_doc_number] => 20090291920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'DETECTION OF STEROID RECEPTORS ON CIRCULATING CARCINOMA CELLS AND TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/296458
[patent_app_country] => US
[patent_app_date] => 2007-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7312
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291920.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296458
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296458 | DETECTION OF STEROID RECEPTORS ON CIRCULATING CARCINOMA CELLS AND TREATMENT | Apr 17, 2007 | Abandoned |
Array
(
[id] => 190593
[patent_doc_number] => 07641903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-05
[patent_title] => 'Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders'
[patent_app_type] => utility
[patent_app_number] => 11/735365
[patent_app_country] => US
[patent_app_date] => 2007-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 19
[patent_no_of_words] => 30011
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/641/07641903.pdf
[firstpage_image] =>[orig_patent_app_number] => 11735365
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/735365 | Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders | Apr 12, 2007 | Issued |
Array
(
[id] => 5521376
[patent_doc_number] => 20090029357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'Method for diagnosing cancer using cancer-associated deletion gene marker'
[patent_app_type] => utility
[patent_app_number] => 11/783723
[patent_app_country] => US
[patent_app_date] => 2007-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4078
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20090029357.pdf
[firstpage_image] =>[orig_patent_app_number] => 11783723
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/783723 | Method for diagnosing cancer using cancer-associated deletion gene marker | Apr 10, 2007 | Abandoned |
Array
(
[id] => 5367740
[patent_doc_number] => 20090305299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Method for Determination of Prognosis of Prostate Cancer, and Diagnostic Agent for Use in the Method'
[patent_app_type] => utility
[patent_app_number] => 12/225998
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3970
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20090305299.pdf
[firstpage_image] =>[orig_patent_app_number] => 12225998
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225998 | Method for determination of prognosis of prostate cancer, and diagnostic agent for use in the method | Mar 29, 2007 | Issued |
Array
(
[id] => 4939408
[patent_doc_number] => 20080076727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/693678
[patent_app_country] => US
[patent_app_date] => 2007-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 19104
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076727.pdf
[firstpage_image] =>[orig_patent_app_number] => 11693678
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/693678 | UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCER | Mar 28, 2007 | Abandoned |
Array
(
[id] => 4965729
[patent_doc_number] => 20080108549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Actin proteins as biomarkers for indication and targeting of resistance and sensitivity to an Abl kinase inhibitor in patients with chronic myelogenous leukemia'
[patent_app_type] => utility
[patent_app_number] => 11/731019
[patent_app_country] => US
[patent_app_date] => 2007-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7231
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108549.pdf
[firstpage_image] =>[orig_patent_app_number] => 11731019
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/731019 | Actin proteins as biomarkers for indication and targeting of resistance and sensitivity to an Abl kinase inhibitor in patients with chronic myelogenous leukemia | Mar 28, 2007 | Abandoned |
Array
(
[id] => 4802634
[patent_doc_number] => 20080014222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Cancer immunotherapy compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/729339
[patent_app_country] => US
[patent_app_date] => 2007-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23415
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20080014222.pdf
[firstpage_image] =>[orig_patent_app_number] => 11729339
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/729339 | Cancer immunotherapy compositions and methods of use | Mar 27, 2007 | Issued |
Array
(
[id] => 5465000
[patent_doc_number] => 20090325200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'POLYPYRIMIDINE-TRACT BINDING PROTEIN (PTB) AS A BIOMARKER AND TARGET FOR THE DIAGNOSIS AND TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/293915
[patent_app_country] => US
[patent_app_date] => 2007-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12659
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325200.pdf
[firstpage_image] =>[orig_patent_app_number] => 12293915
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/293915 | POLYPYRIMIDINE-TRACT BINDING PROTEIN (PTB) AS A BIOMARKER AND TARGET FOR THE DIAGNOSIS AND TREATMENT OF CANCER | Mar 22, 2007 | Abandoned |
Array
(
[id] => 5285419
[patent_doc_number] => 20090099094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Use of Somatostatin Agonists to Treat Medullary Thyroid Carcinoma'
[patent_app_type] => utility
[patent_app_number] => 12/225492
[patent_app_country] => US
[patent_app_date] => 2007-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18621
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099094.pdf
[firstpage_image] =>[orig_patent_app_number] => 12225492
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225492 | Use of Somatostatin Agonists to Treat Medullary Thyroid Carcinoma | Mar 22, 2007 | Abandoned |
Array
(
[id] => 4710658
[patent_doc_number] => 20080299184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Anticancer agent'
[patent_app_type] => utility
[patent_app_number] => 11/723694
[patent_app_country] => US
[patent_app_date] => 2007-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9927
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299184.pdf
[firstpage_image] =>[orig_patent_app_number] => 11723694
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/723694 | Anticancer agent | Mar 20, 2007 | Issued |
Array
(
[id] => 6254627
[patent_doc_number] => 20100028914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'ASSESSING LUNG NODULES'
[patent_app_type] => utility
[patent_app_number] => 12/293318
[patent_app_country] => US
[patent_app_date] => 2007-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4477
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028914.pdf
[firstpage_image] =>[orig_patent_app_number] => 12293318
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/293318 | ASSESSING LUNG NODULES | Mar 15, 2007 | Abandoned |
Array
(
[id] => 5538698
[patent_doc_number] => 20090220503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'METHOD FOR TREATING CANCERS WITH INCREASED RAS SIGNALING'
[patent_app_type] => utility
[patent_app_number] => 12/282432
[patent_app_country] => US
[patent_app_date] => 2007-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 22635
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220503.pdf
[firstpage_image] =>[orig_patent_app_number] => 12282432
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/282432 | METHOD FOR TREATING CANCERS WITH INCREASED RAS SIGNALING | Mar 11, 2007 | Abandoned |
Array
(
[id] => 5309779
[patent_doc_number] => 20090017060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => 'Cleavable Vaccine Compositions and Uses Thereof and Methods of Making and Using the Same'
[patent_app_type] => utility
[patent_app_number] => 12/281229
[patent_app_country] => US
[patent_app_date] => 2007-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16460
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20090017060.pdf
[firstpage_image] =>[orig_patent_app_number] => 12281229
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/281229 | Cleavable vaccine compositions and uses thereof and methods of making and using the same | Mar 8, 2007 | Issued |
Array
(
[id] => 5354698
[patent_doc_number] => 20090186042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/280389
[patent_app_country] => US
[patent_app_date] => 2007-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 36164
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186042.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280389
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280389 | IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER | Feb 26, 2007 | Abandoned |
Array
(
[id] => 5367166
[patent_doc_number] => 20090304725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Vaccine and Antigen Mimotopes Against Cancerous Diseases Associated with the Carcinoembryonic Antigen CEA'
[patent_app_type] => utility
[patent_app_number] => 12/278343
[patent_app_country] => US
[patent_app_date] => 2007-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4429
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304725.pdf
[firstpage_image] =>[orig_patent_app_number] => 12278343
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/278343 | Vaccine and Antigen Mimotopes Against Cancerous Diseases Associated with the Carcinoembryonic Antigen CEA | Feb 4, 2007 | Abandoned |
Array
(
[id] => 5005496
[patent_doc_number] => 20070203067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties'
[patent_app_type] => utility
[patent_app_number] => 11/656009
[patent_app_country] => US
[patent_app_date] => 2007-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3167
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203067.pdf
[firstpage_image] =>[orig_patent_app_number] => 11656009
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/656009 | Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties | Jan 21, 2007 | Issued |
Array
(
[id] => 5095559
[patent_doc_number] => 20070117168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Perinucleolar compartment as a cancer marker'
[patent_app_type] => utility
[patent_app_number] => 11/651733
[patent_app_country] => US
[patent_app_date] => 2007-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8800
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117168.pdf
[firstpage_image] =>[orig_patent_app_number] => 11651733
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/651733 | Perinucleolar compartment as a cancer marker | Jan 9, 2007 | Issued |